AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Clinical trials for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE explained in plain language.
Never miss a new study
Get alerted when new AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE trials appear
Sign up with your email to follow new studies for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's agitation drug safety study halted
Symptom relief TerminatedThis study aimed to check the long-term safety of AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had completed previous trials of the same medication. The trial was terminated, meaning it ended early before reaching its planned …
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Major trial tests new pill for Alzheimer's agitation
Symptom relief TerminatedThis was a long-term study to check the safety and see if a drug called AVP-786 could continue to help control agitation in people with Alzheimer's disease. The study involved nearly 1,200 participants who had already been in related shorter trials. The main goal was to monitor s…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Mar 25, 2026 14:09 UTC